Fenómeno de Raynaud. Revisión

作者: Jairo Alonso Rodríguez-Criollo , Daniel Jaramillo-Arroyave , Daniel Jaramillo-Arroyave

DOI: 10.15446/REVFACMED.V62N3.38934

关键词:

摘要: Raynaud's phenomenon is an exaggerated vascular response to cold or stress manifested by skin colour changes at several locations, having three characteristic phases: pallor (white), cyanosis (blue) and rubor (red). When the cause not known this termed primary  Raynaud's secondary when underlying disease involved, autoimmune being most frequent of form. Primary has a good prognosis can be treated medically without need for specialist assessment, unlike which needs assessment treatment. A general practitioner know classification, basis treatment signs symptoms control patient requires evaluation according other diseases may present coexist.

参考文章(47)
Ariane L. Herrick, Maurizio Cutolo, Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis. Arthritis & Rheumatism. ,vol. 62, pp. 2595- 2604 ,(2010) , 10.1002/ART.27543
AE Gliddon, CJ Doré, CM Black, N McHugh, R Moots, CP Denton, A Herrick, T Barnes, J Camilleri, K Chakravarty, P Emery, B Griffiths, ND Hopkinson, P Hickling, P Lanyon, C Laversuch, T Lawson, R Mallya, M Nisar, C Rhys‐Dillon, T Sheeran, PJ Maddison, None, Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double‐blind, placebo‐controlled trial of the angiotensin‐converting enzyme inhibitor quinapril Arthritis & Rheumatism. ,vol. 56, pp. 3837- 3846 ,(2007) , 10.1002/ART.22965
JCR Bowling, PM Dowd, Raynaud's disease. The Lancet. ,vol. 361, pp. 2078- 2080 ,(2003) , 10.1016/S0140-6736(03)13646-X
Ariane L. Herrick, The pathogenesis, diagnosis and treatment of Raynaud phenomenon Nature Reviews Rheumatology. ,vol. 8, pp. 469- 479 ,(2012) , 10.1038/NRRHEUM.2012.96
H.R. Maricq, E. C. LeRoy, W. A. D'Angelo, T. A. Medsger, G. P. Rodnan, G. C. Sharp, J. F. Wolfe, Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders Arthritis & Rheumatism. ,vol. 23, pp. 183- 189 ,(1980) , 10.1002/ART.1780230208
Ethan S. Weiner, Sabine Hildebrandt, Jean-Luc Senécal, Lesley Daniels, Steven Noell, France Joyall, André Roussin, William Earnshaw, Naomi F. Rothfield, Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study. Arthritis & Rheumatism. ,vol. 34, pp. 68- 77 ,(1991) , 10.1002/ART.1780340111
EVLIN L. KINNEY, GARY G. NICHOLAS, JOSEPH GALLO, CHARLENE PONTORIERO, ROBERT ZELIS, The Treatment of Severe Raynaud's Phenomenon with Verapamil The Journal of Clinical Pharmacology. ,vol. 22, pp. 74- 76 ,(1982) , 10.1002/J.1552-4604.1982.TB05712.X